Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who started this subject	4/6/2002 12:54:44 PM
From: nigel bates	Read Replies (1) of 684

Another not quite biotech - INMX Cap around $32.5m. Should be able to continue drifting aimlessly for maybe another 12 months and still be sub cash... Who knows, they may even get their act together ? ...On a GAAP basis, the Company estimates a net loss of $7.8 million for the first quarter ended March 31, 2002 compared to a GAAP net loss of $4.2 million for the first quarter of 2001.... `We plan to provide guidance on our strategic plan and financial outlook at the beginning of May, when final results for our first quarter will be announced. With a strong balance sheet that includes a cash position of over $57 million and favorable operating cost trends, we have the financial flexibility, cost discipline and market position to build a profitable, long-term growth business.'' ``Looking forward, we remain very optimistic about the long-term demand for life science informatics software solutions and services and the opportunity for InforMax to further solidify its leadership position...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next